NEW YORK (GenomeWeb News) – French molecular diagnostics firm IntegraGen today said that revenues during the first half of 2013 increased 18 percent year over year.

The company, which develops MDx tests for autism and cancer, said that during the first six months of the year it posted revenues of €2.7 million ($3.7 million), compared to €$2.3 million a year ago. IntegraGen preannounced preliminary first-half 2013 revenues in July.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The apple has traveled westward and eastward along the Silk Road, according to a new genetic analysis.

In Nature this week: GWAS data used to reposition drugs for psychiatric use, and more.

Genetic disease risk information doesn't always spur people to make healthy lifestyle changes, according to the Associated Press.

A University of California, San Diego-led team has used liquid biopsies to uncover possible treatments for patients with cancers of unknown primary.